Blog
Discover all our content dedicated to project management, strategy, coordination and development of drugs or medical devices. Our qualified experts share with you all the news of the health sector… Pharma, biotech, medtech, e-health.
Sign up to our newsletter to stay up to date with the latest news and views from HC NEXT
Discover all our articles
Medtech, Biotech, E-health
The crucial importance of project management for healthcare startups
Project management ultimately allows a translation of a high-level roadmap into a crystal-clear executable action plan with intermediate milestones.
April 7, 2023
How to Manage Clinical Trials for Startups
Clinical trials are crucial for bringing new medical innovations to market, but they can be particularly challenging for startups. Effective project management is essential to navigate these complexities, ensuring that
Healthcare Startup – Investment Due Diligence Checklist
Investing in healthcare startups can be rewarding, however, it comes with unique challenges and risks. Thorough due diligence is essential to minimize these risks and make informed investment decisions. This checklist
Navigating the Development Challenges in eHealth Technologies
In recent years, the integration of technology into healthcare, commonly referred to as eHealth, has revolutionized the way we approach medical services, patient care, and health management. From telemedicine platforms
Creating Connected Health Objects: Revolutionizing Healthcare through IoT
What process for creating connected health objects and what are their potential benefits in advancing healthcare? Many of you are still questionning it and I will humbly try here to
e-health startup product development and health data processing
E-health startups have been on the rise in recent years, with many entrepreneurs looking to capitalize on the opportunities presented by the digital health market. One of the key challenges
The crucial importance of project management for healthcare startups
In an effervescent healthcare innovation field, where risk-assessment and time-to-market are key to break-through and survive, speeding and derisking drugs and medical devices developments to ensure that each innovation becomes